US Stock MarketDetailed Quotes

LXEO Lexeo Therapeutics

Watchlist

7.410
+0.180+2.49%

Trading Nov 26 11:12 ET

245.02MMarket Cap-2829P/E (TTM)

Lexeo Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Lexeo Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 0.000	--
--	2024/Q4	-- / 0.000	--
--	2024/Q3	0.000 / 0.000	--
--	2024/Q2	0.000 / 0.000	--
--	2024/Q1	0.000 / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 0.000--

--2024/Q4-- / 0.000--

--2024/Q30.000 / 0.000--

--2024/Q20.000 / 0.000--

--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Open Account

Lexeo Therapeutics Earnings Reports

Lexeo Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 13 07:38 ET

Lexeo Therapeutics | 8-K: Lexeo Therapeutics Provides Update on Cardiac Portfolio and Reports Third Quarter 2024 Financial Results

Nov 13 07:33 ET

Lexeo Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 12 07:05 ET

Lexeo Therapeutics | 8-K: Lexeo Therapeutics Reports Second Quarter 2024 Financial Results and Operational Highlights

Aug 12 07:05 ET

Analyst Rating

Updated: Nov 21, 2024

Strong Buy

Buy
100.00%
Hold
0.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall